BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests accessible to all, announced today several abstract presentations that will be showcased at the ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Omaha-based healthcare company Fusion has selected this year's recipients of the Compassion in Care Scholarship program which aims to assist students pursuing a nursing career. This year's recipients ...

Through its Precision Care Companion, McKesson wants to help oncologists bring personalized medicine to their patients ...

A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson’s disease in body fluids.

ICMR-NICPR announces DHR sponsored training course on omics technologies: Shardul Nautiyal, Mumbai Saturday, April 26, 2025, 08:00 Hrs [IST] In a significant leap towards advancin ...

Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and metabolic diseases, today announced that a poster ...

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don't know what causes it.

Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are ...